Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose vs Conventional Chemotherapy in Metastatic Poor Prognosis Germ Cell Tumors
NCT02161692Phase 2Completed
- Sponsor
- Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano
- Start
- Dec 1996
- Primary completion
- May 2007
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide, carboplatin in germ cell tumor (GCT), sponsored by Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano. Started Dec 1996; status: completed.
02
Drugs
cyclophosphamidecarboplatin
03
Conditions
germ cell tumor (GCT)
Beyond the preview
Go deeper on NCT02161692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02161692.